FDA has rejected Neuralink’s application for brain-computer interface human trials
The US Food and Drug Administration (FDA) has rejected Neuralink, a brain-machine interface application company owned by Elon Musk, from conducting human trials due to concerns about the potential impact of the lithium batteries...
